secwatch.observer — SEC 8-K summary
======================================

Issuer:     InspireMD, Inc. (NSPR)
CIK:        0001433607
Form:       8-K
Filed at:   2023-03-20T23:59:59+00:00
Accession:  0001493152-23-008192
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InspireMD promotes Andrea Tommasoli to COO, effective March 19, 2023
--------------------------------------------------------------------

- Tommasoli previously served as SVP of Global Sales & Marketing since November 2020.
- New annual base salary of €240,000 (≈ $258,000) plus yearly bonus of 35% of base salary.
- CEO Marvin Slosman cited Tommasoli's role in expanding CGuard EPS in EU and preparing for U.S. approval.
- Tommasoli has prior commercial leadership at Integra LifeSciences and St. Jude Medical (Abbott).
- Employment agreement has indefinite term with six months' notice period for termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1433607/000149315223008192/0001493152-23-008192-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1433607/000149315223008192/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-008192

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer